Why the study?
Does comorbidity influence the choice of treatment in patients with localized prostate cancer?
Population
2,941 patients with newly diagnosed prostate cancer between 1993 and 1996 in the southern part of The…
Design
Cohort
Authors
Loading...
Comorbidity prevalence rises with age yet rarely sways radical prostatectomy decisions; leaves open whether age-driven selection overlooks comorbidity risks in localized prostate cancer.
Does comorbidity influence the choice of treatment in patients with localized prostate cancer?
In patients with localized prostate cancer, treatment choice is largely driven by patient age and urologist experience rather than the presence of comorbidities.
Post et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: